Steven Fein, MD

home / authors / steven-fein-md

Steven Fein, MD, is a telehealth hematologist with HemeOnCall.

Articles

Steven Fein, MD | Credit: University of Michigan

Improving Management of Iron Deficiency, with Steven Fein, MD

Steven Fein, MD
December 18th 2024

Read More

Steven Fein, MD | Credit: University of Michigan

Updates, News in Sickle Cell Disease, with Steven Fein, MD

Steven Fein, MD
December 18th 2024

Steven Fein, MD, discusses news and updates in sickle cell disease following ASH 2024.

Read More

Steven Fein, MD | Credit: University of Michigan

Hematology Pipelines, Trials to Watch, with Steven Fein, MD

Steven Fein, MD
December 18th 2024

In this video, a hematologist discusses trials and areas of advancement he is excited about in the current landscape.

Read More

Steven Fein, MD | Credit: University of Michigan

Clinically Relevant Updates in Iron Deficiency, with Steven Fein, MD

Steven Fein, MD
December 18th 2024

In part 2 of our 5-part series, Steven Fein, MD, discusses updates in iron deficiency management from 2024.

Read More

Steven Fein, MD | Credit: University of Michigan

Recapping ASH 2024 Highlights, with Steven Fein, MD

Steven Fein, MD
December 18th 2024

In this video, Steven Fein, MD, discusses updates and topics of note from the American Society of Hematology annual meeting.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Scott Bartley, MD I Credit: LinkedIn
Published: December 16th 2024 | Updated: December 18th 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 18th 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
FDA Approves Nemolizumab for Individuals with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 18th 2024
FDA Approves Nemolizumab for Individuals with Atopic Dermatitis
Jörn M. Schattenberg, MD | Credit: LinkedIn
Published: December 15th 2024 | Updated: December 18th 2024
Study Highlights Real-World Mortality Rates, Factors Increasing Mortality Risk in MASH
© 2024 MJH Life Sciences

All rights reserved.